Effect of Sleep and Sleep Deprivation on Serotonergic Neurotransmission in the Hippocampus: a Combined in Vivo Microdialysis/EEG Study in Rats
Overview
Authors
Affiliations
Brainstem serotonergic neurotransmission is implicated in sleep regulation. However, the role of serotonin (5-HT) in forebrain regions in sleep-wake mechanisms is still unclear. Here, we have investigated, using a combined in vivo microdialysis/electroencephalogram method, the relationship between hippocampal 5-HT levels and sleep-wake behaviour in the rat. A clear-cut relationship was found between hippocampal 5-HT levels and vigilance state. The highest levels of 5-HT were observed during wakefulness, whereas a progressive decrease of 5-HT going from nonrapid eye movement sleep to rapid eye movement sleep was found. Sleep deprivation (SD) causes a transient enhancement of mood in depressed patients. Given the putative role of 5-HT in the aetiology of depression and the therapeutical efficacy of selective serotonin reuptake inhibitors in this illness, we also studied hippocampal 5-HT during 4 h of SD and during the subsequent recovery period. During the whole SD period, 5-HT levels were elevated substantially when compared to 5-HT levels during basal wakefulness. However, no changes in 5-HT levels and the relationship between hippocampal 5-HT and vigilance state were found during the subsequent recovery period. As SD is a potentially stressful experience and glucocorticoids are involved in the regulation of serotonergic neurotransmission and sleep, we investigated the effects of SD on free corticosterone levels. SD caused a marked rise in free corticosterone levels. However, the effects of SD on 5-HT seem not to be mediated by this hormone, because adrenalectomy did not affect the rise in hippocampal 5-HT during SD. We hypothesize that the elevated hippocampal 5-HT levels during SD may participate in the transient mood enhancing properties of forced wakefulness observed in depressed patients.
Sleep and Learning: A Systematic Review.
Gutierrez Perez M, Lugo Machado J, Lozano Lavado V, Navarro Pimiento D Int Arch Otorhinolaryngol. 2024; 28(4):e657-e661.
PMID: 39464363 PMC: 11511274. DOI: 10.1055/s-0043-1777294.
Witkowska A, Jaromirska J, Gabryelska A, Sochal M Int J Mol Sci. 2024; 25(17).
PMID: 39273373 PMC: 11395478. DOI: 10.3390/ijms25179427.
4-Hydroxybenzyl alcohol derivatives and their sedative-hypnotic activities.
Zhu H, Zhang D, Zhang Q, Zhao Y, He Z, Gao Y RSC Adv. 2022; 8(35):19539-19550.
PMID: 35540981 PMC: 9080670. DOI: 10.1039/c8ra01972j.
Kroll T, Kornadt-Beck N, Oskamp A, Elmenhorst D, Touma C, Palme R Animals (Basel). 2021; 11(3).
PMID: 33807941 PMC: 8001186. DOI: 10.3390/ani11030710.
Oh J, Yoo J, Ko S, Kang J, Lee S, Jeong W Saf Health Work. 2021; 12(1):102-107.
PMID: 33732534 PMC: 7940138. DOI: 10.1016/j.shaw.2020.10.004.